It was reported that a patient underwent an unknown procedure on an unknown date and absorbable hemostat was used.The patient had osteomyelitis and performed surgery.Absorbable hemostat was sprayed for bleeding control and the clots are good looking.However, after that, there was an inflammatory reaction, and a lot of water came out while the patient stay hospital.The surgeon tried to re-op again and when the clot was examined again, and candida bacteria were found.Additional information was requested.
|
Product complaint # (b)(4).H6.Component code: g07002 - device not returned.To date the device has not been returned.If the device or further details are received at a later date a supplemental medwatch will be sent.Attempts are being made to obtain the following information.To date no response has been provided.If further details are received at a later date a supplemental medwatch will be sent.1.Please provide the following patient demographic information, if available: age, gender, weight, bmi at the time of index procedure? 2.What are the name and date of index surgical procedure? 3.Please provide any relevant patient history: patient pre-existing medical conditions (i.E.Allergies, history of reactions), all concomitant medications, past medical history, any treatment required for events, dose, frequency, and therapy dates.4.Was there any intraoperative concurrent use of other products? 5.What is the lot number? 6.Where was the surgicel used (on what tissue)? 7.How much surgicel was used during the procedure? 8.Was the surgicel product left in place? was the excess irrigated and removed? 9.What were current symptoms following the index surgical procedure? onset date? 10.Were cultures performed? if yes, results? 11.Has any surgical or medical intervention been performed? 12.What is physician¿s opinion as to the cause of or contributing factors to this event? 13.Was there an alleged deficiency of the surgicel that contributed to the patient¿s post-operative inflammatory reaction? 14.What is the patient¿s current status? 15.What is the users experience w/ surgicel powder and other hemostatic agents? 16.Has the surgeon been advised to submit a medical information request regarding their inquiry, ¿the customer's request was that the surgicel powder prevents mrsa and mrse, but the surgeon was curious about how it forms a shield against candida bacteria.¿ this report is being submitted pursuant to the provisions of 21 cfr part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by ethicon, or its employees that the report constitutes an admission that the product, ethicon, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.
|